Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · CBD

CBD in Timor-Leste: not individually verified

Not individually verified

We have not confirmed that CBD specifically is scheduled in Timor-Leste, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. Not named by that term anywhere in Anexo II to Lei n.º 2/2017, de 25 de Janeiro; a direct search for "canabidiol" returned no match. The same two routes worked through for cannabinol (see that cell) were tested for cbd, and both are weaker here, so neither is asserted here as the governing capture. Tabela I-C's "Cannabis, resina de" and "Cannabis, óleo de" entries ("resina separada, em bruto ou purificada, obtida a partir da planta Cannabis"; "óleo separado, em bruto ou purificado, obtido a partir da planta Cannabis") describe a whole plant extract calibrated by Delta-9-THC content, which is the form most cbd is actually sold in (an oil or extract drawn from the cannabis plant); read that way, a cbd-rich extract sold as "óleo" could fall inside item 3's plain words, though Table I-C carries no isomer or derivative extension clause and the Annex I notes calibrate resin and oil strictly by THC concentration, not cbd concentration, which supports reading these entries as THC-focused products rather than cbd ones. A pure, isolated cbd compound, as distinct from a plant oil or resin, is the weaker case for this route, since it is the least common commercial form and furthest from "obtida a partir da planta" read as describing an extraction process rather than a single molecule. The Tabela II-B route available for cannabinol does not transfer to cbd: cbd and tetrahydrocannabinol (item 14) are both synthesised in the cannabis plant from the common precursor cannabigerolic acid by different enzymes; cbd is not a chemical derivative of tetrahydrocannabinol, nor does ordinary biosynthesis run from tetrahydrocannabinol to cbd, so Table II-B's closing "derivados" clause does not reach cbd the way it reaches cannabinol's oxidation relationship to item 14. Article 5's hallucinogen and amphetamine-type criteria at 5.2(d)-(e) are drafting criteria for how the tables were compiled, not an operative catch-all; that reading is applied here as it is for cannabinol. Because neither route reaches a pure cbd isolate with confidence, that is not treated here as a settled negative answer either: Lei n.º 2/2017 does not close itself, since article 3(3) allows the tables to be altered by law or updated in line with changes to the international Conventions, and whether that updating clause self-executes without a further legislative act is not resolved on the text read.

Confirm directly with Timor-Leste’s national drug authority or your own embassy before you rely on anything.

What Timor-Leste HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.